In patients with "final common pathway" malignant melanoma, there was a highly significant deficiency in macrophage precursors (MPs).
← all excerpts
Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.
1
—
—
In patients with "final common pathway" malignant melanoma, there was a highly significant deficiency in macrophage precursors (MPs).